New York Gov. Kathy Hochul signed a bill into law that will require health insurers to cover EpiPens and caps the amount consumers will be required to pay out of pocket at $100, her office announced Thursday.

EpiPen devices are used to allergic reactions for people who are at risk or have a history of anaphylaxis, which can be caused by insect bites or stings, foods, medications, environmental exposures, exercise and other unknown causes.

According to the governor’s office, the cost of EpiPen devices has outpaced the rate of inflation, with some reports citing a 600% increase in price since 2007. While EpiPens once cost $60 per device, they can now sell for upwards of $600 for a pack of two pens. The new law will make health insurers in the individual and group markets, which includes non-profit insurers and HMOs, to cover medically necessary EpiPens. The state Legislature passed the legislation in May.

“For people with severe allergies, immediate access to an EpiPen device can mean the difference between life and death,” Hochul said in a statement. “When every second counts, the last thing New Yorkers should have to worry about is whether they can afford the medication they need to survive an anaphylactic reaction. By signing this bill, we are putting people over profit and giving New Yorkers peace of mind by ensuring equitable access to this lifesaving emergency treatment.”